At 48 weeks, a weight reduction of 5% or more, 10% or more, and 15% or more had occurred in 92%, 75%, and 60%, respectively, of the participants who received 4 mg of retatrutide
This distinction was evident when the Michigan BCBS recently announced some changes to their coverage of GLP-1 medications
A recent study published in The Lancet Diabetes & Endocrinology found that the use of GLP-1 receptor agonists, a class of drugs that includes Ozempic, during pregnancy was not associated with an increased risk of major birth defects or other adverse pregnancy outcomes
"The effect of feeding untreated rapeseed and iodine supplement on egg quality" (PDF)
Pancreatitis : In rare cases, an overdose may increase the risk of developing pancreatitis, which can manifest as severe abdominal pain, nausea, and vomiting
Wegovy is self-administered once weekly alongside increased exercise and a reduced-calorie diet